HCA Healthcare, Inc. $HCA Shares Sold by Hennessy Advisors Inc.

Hennessy Advisors Inc. decreased its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 2.3% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 8,500 shares of the company’s stock after selling 200 shares during the quarter. Hennessy Advisors Inc.’s holdings in HCA Healthcare were worth $3,256,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. Price T Rowe Associates Inc. MD grew its position in HCA Healthcare by 83.4% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 2,399,372 shares of the company’s stock worth $829,104,000 after purchasing an additional 1,091,416 shares in the last quarter. Goldman Sachs Group Inc. grew its position in HCA Healthcare by 49.1% during the 1st quarter. Goldman Sachs Group Inc. now owns 1,781,459 shares of the company’s stock worth $615,583,000 after purchasing an additional 587,036 shares in the last quarter. Nuveen LLC purchased a new position in HCA Healthcare during the 1st quarter worth approximately $569,217,000. Pacer Advisors Inc. grew its position in HCA Healthcare by 6,237.9% during the 1st quarter. Pacer Advisors Inc. now owns 1,350,933 shares of the company’s stock worth $466,815,000 after purchasing an additional 1,329,618 shares in the last quarter. Finally, Principal Financial Group Inc. grew its position in HCA Healthcare by 0.8% during the 1st quarter. Principal Financial Group Inc. now owns 880,663 shares of the company’s stock worth $304,313,000 after purchasing an additional 6,888 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have weighed in on HCA shares. Morgan Stanley lowered their price target on shares of HCA Healthcare from $410.00 to $400.00 and set an “equal weight” rating on the stock in a report on Monday, July 28th. Wolfe Research cut shares of HCA Healthcare from an “outperform” rating to a “peer perform” rating in a report on Monday, July 28th. Wells Fargo & Company lowered their price target on shares of HCA Healthcare from $385.00 to $375.00 and set an “equal weight” rating on the stock in a report on Thursday, August 14th. Cantor Fitzgerald restated an “overweight” rating and set a $444.00 price target on shares of HCA Healthcare in a report on Tuesday, August 26th. Finally, Truist Financial boosted their price target on shares of HCA Healthcare from $390.00 to $415.00 and gave the company a “buy” rating in a report on Wednesday, July 16th. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and nine have issued a Hold rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $407.75.

HCA Healthcare Trading Up 0.7%

HCA stock opened at $429.52 on Friday. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $432.36. The company has a fifty day simple moving average of $397.53 and a 200 day simple moving average of $372.65. The firm has a market cap of $100.50 billion, a PE ratio of 18.05, a PEG ratio of 1.35 and a beta of 1.40.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.20 by $0.64. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The business had revenue of $18.61 billion during the quarter, compared to analyst estimates of $18.49 billion. During the same quarter in the previous year, the business earned $5.50 EPS. HCA Healthcare’s quarterly revenue was up 6.4% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th were given a $0.72 dividend. This represents a $2.88 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend was Tuesday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is currently 12.11%.

Insider Activity

In other news, EVP Michael S. Cuffe sold 3,836 shares of the firm’s stock in a transaction dated Monday, September 8th. The stock was sold at an average price of $418.84, for a total value of $1,606,670.24. Following the sale, the executive vice president directly owned 31,503 shares of the company’s stock, valued at approximately $13,194,716.52. This trade represents a 10.85% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 1.30% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.